Lexicon Pharmaceuticals, Inc. LXRX
NASDAQ · United States · Health Technology
$1.85-0.02 (-1.33%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.07 | -0.05 | -39.4% | $692.00K | -82.7% | +0.8%$2.45→$2.47 |
| Q1 2026 | 2026-05-07 | 0.00 | -0.04 | +100.0% | — | — | +25.0%$1.60→$2.00 |
| Q4 2025 | 2026-03-05 | -0.04 | -0.07 | +42.9% | — | — | +4.9%$1.63→$1.71 |
| Q3 2025 | 2025-11-06 | -0.04 | -0.07 | +42.9% | — | — | -9.4%$1.38→$1.25 |
| Q2 2025 | 2025-08-06 | 0.01 | -0.08 | +112.5% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.07 | -0.10 | +30.0% | — | — | — |
| Q4 2024 | 2025-03-06 | -0.09 | -0.12 | +25.0% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.18 | -0.17 | -5.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.